Ocata Therapeutics Inc fka OCAT

[rumit]

So what does our group think of this line in the presentation?

"Developing IND submission for red blood cells and/or platelets derived from iPS cells"

I find this, now that it is in writing, very intriguing.

Raises more questions.. how will we pay for this? We have funding for RPE trials but thats about it.

Will CHA assist? Someone else? Looking for suitors? It doesn't seem like we are looking for a funding partner for this IND if the only mention of the program is a tiny bullet point at the end of a presentation.